Tandem Diabetes Care (TNDM) Total Debt Growth (1y) (2014 - 2018)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Total Debt Growth (1y) (2014 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | - |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 12.29% |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 3.24% |
| Mar 31, 2018 | 3.58% |
| Dec 31, 2017 | -3.06% |
| Sep 30, 2017 | 69.19% |
| Jun 30, 2017 | 68.20% |
| Mar 31, 2017 | 67.24% |
| Dec 31, 2016 | 169.72% |
| Sep 30, 2016 | 51.47% |
| Jun 30, 2016 | 50.61% |
| Mar 31, 2016 | 49.72% |
| Dec 31, 2015 | -0.56% |
| Sep 30, 2015 | 0.28% |
| Jun 30, 2015 | 0.29% |
| Mar 31, 2015 | 0.05% |
| Dec 31, 2014 | 0.15% |